E-cigarette vapor contains more carcinogenic formaldehyde than regular cigarettes

Share this content:

the ONA take:

E-cigarette vapor may contain cancer-causing formaldehyde at a level 15 times higher than normal cigarettes, according to a new study published in the New England Journal of Medicine.

“We’ve found that there is a hidden form of formaldehyde in e-cigarette vapor that has not typically been measured,” said James Pankow, PhD, co-author of the study along with fellow researchers at Portland State University in Oregon. “People shouldn’t assume these e-cigarettes are completely safe.”

While once believed to be a less harmful alternative to the formaldehyde and toxic chemicals found in the smoke of normal cigarettes, newer e-cigarettes operate at high temperatures that dramatically boost the creation of formaldehyde-containing compounds.

The researchers found that, at high voltage, formaldehyde-releasing agents in e-cigarettes increased a person’s lifetime risk of cancer by five-to-15 times greater than the risk of long-term smoking with regular cigarettes. However, the compounds were not found when they were operated at a lower voltage.

The American Vaping Association, an advocacy group for e-cigarette makers, criticized the study, stating that users wouldn’t normally operate devices at such a high voltage.

E-cigarettes remain unregulated, and representatives from the American Cancer Society stated that the findings from the study stress the importance of FDA oversight.

E-cigarettes don't help cancer patients stop smoking
E-cigarette vapor may contain cancer-causing formaldehyde at a level 15 times higher than normal cigarettes.
E-cigarette vapor can contain cancer-causing formaldehyde at levels up to 15 times higher than regular cigarettes, a new study finds. This could pose a risk to users who increase the voltage on their e-cigarette to increase the delivery of vaporized nicotine, said study co-author James Pankow, a professor of chemistry and civil and environmental engineering at Portland State University in Oregon.
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs